Supreme Court Declares in the Long-Lasting Trademark Combat That the Attention Level for Unprescribed Medicines Is No Different Than the Prescribed Ones.
Supreme Court Assembly of Civil Chambers has rendered a significant decision (E. 2017/413, K. 2021/1127 T. 30.09.2021) on the long-lasting trademark combat between the pharma trademarks.
In the precedent, the plaintiff- owner of the “ZINCO” trademark covering the goods in class 05– filed a cancellation action against the Turkish PTO’s decision refusing its opposition to the latter application for “ZINCOBEST” covering class 05.
